Jennifer is the Chief Commercial Officer and General Manager of the R&D Solutions Business Unit at Ginkgo Bioworks, where she leads the BioPharma R&D business including technical and operational teams. Jennifer’s focus is on driving the growth of Ginkgo’s BioPharma R&D services, delivering innovative solutions for customers across the synthetic biology and biotech sectors. She manages the entire business cycle—from commercial strategy and execution to technical development and operational execution through to successful customer outcomes at scale.

Prior to her current role, Jennifer led Ginkgo’s commercial function, where she played a key role in growing the company’s cell engineering business. Before joining Ginkgo, Jennifer spent more than a decade at Merck & Co., gaining extensive experience in vaccine development, domestic and international plant management, and U.S. market commercial operations.

Jennifer holds an M.S. in Chemical Engineering from Stanford University and a B.S. in Bioengineering from the University of Arizona.